Lederer & Associates Investment Counsel’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.23M | Buy |
9,603
+84
| +0.9% | +$9.83K | 0.81% | 43 |
|
|
2026
Q1 | $1.15M | Sell |
9,519
-145
| -2% | -$16.7K | 0.81% | 44 |
|
|
2025
Q4 | $1.02M | Sell |
9,664
-69
| -0.7% | -$6.48K | 0.68% | 48 |
|
|
2025
Q3 | $817K | Sell |
9,733
-689
| -7% | -$56.8K | 0.53% | 59 |
|
|
2025
Q2 | $825K | Buy |
10,422
+1,479
| +17% | +$118K | 0.55% | 62 |
|
|
2025
Q1 | $803K | Sell |
8,943
-25
| -0.3% | -$2.33K | 0.59% | 58 |
|
|
2024
Q4 | $892K | Buy |
8,968
+1,119
| +14% | +$115K | 0.62% | 56 |
|
|
2024
Q3 | $891K | Hold |
7,849
| – | – | 0.63% | 55 |
|
|
2024
Q2 | $972K | Sell |
7,849
-880
| -10% | -$113K | 0.7% | 47 |
|
|
2024
Q1 | $1.15M | Sell |
8,729
-1,130
| -11% | -$139K | 0.8% | 45 |
|
|
2023
Q4 | $1.07M | Sell |
9,859
-138
| -1% | -$14.3K | 0.8% | 45 |
|
|
2023
Q3 | $1.03M | Buy |
9,997
+58
| +0.6% | +$6.25K | 0.82% | 44 |
|
|
2023
Q2 | $1.15M | Buy |
9,939
+285
| +3% | +$32.4K | 0.87% | 43 |
|
|
2023
Q1 | $1.03M | Buy |
9,654
+2,303
| +31% | +$249K | 0.79% | 48 |
|
|
2022
Q4 | $816K | Sell |
7,351
-5,202
| -41% | -$532K | 0.67% | 55 |
|
|
2022
Q3 | $1.08M | Sell |
12,553
-283
| -2% | -$25.3K | 0.91% | 42 |
|
|
2022
Q2 | $1.17M | Buy |
12,836
+34
| +0.3% | +$3.01K | 0.9% | 44 |
|
|
2022
Q1 | $1.05M | Buy |
12,802
+65
| +0.5% | +$5.13K | 0.64% | 56 |
|
|
2021
Q4 | $976K | Buy |
12,737
+2,133
| +20% | +$170K | 0.57% | 61 |
|
|
2021
Q3 | $796K | Buy |
10,604
+3,510
| +49% | +$267K | 0.51% | 60 |
|
|
2021
Q2 | $552K | Sell |
7,094
-115
| -2% | -$8.55K | 0.37% | 66 |
|
|
2021
Q1 | $530K | Buy |
7,209
+1,044
| +17% | +$77K | 0.37% | 65 |
|
|
2020
Q4 | $481K | Buy |
6,165
+1,282
| +26% | +$98K | 0.37% | 62 |
|
|
2020
Q3 | $386K | Buy |
4,883
+408
| +9% | +$32K | 0.32% | 64 |
|
|
2020
Q2 | $330K | Sell |
4,475
-126
| -3% | -$9.48K | 0.31% | 64 |
|
|
2020
Q1 | $338K | Buy |
4,601
+1,336
| +41% | +$105K | 0.38% | 64 |
|
|
2019
Q4 | $283K | Sell |
3,265
-62
| -2% | -$5.09K | 0.25% | 80 |
|
|
2019
Q3 | $267K | Sell |
3,327
-110
| -3% | -$8.82K | 0.26% | 82 |
|
|
2019
Q2 | $275K | Sell |
3,437
-661
| -16% | -$50.6K | 0.25% | 82 |
|
|
2019
Q1 | $325K | Sell |
4,098
-319
| -7% | -$23.9K | 0.3% | 73 |
|
|
2018
Q4 | $322K | Sell |
4,417
-467
| -10% | -$33K | 0.34% | 70 |
|
|
2018
Q3 | $331K | Sell |
4,884
-63
| -1% | -$4.01K | 0.28% | 75 |
|
|
2018
Q2 | $287K | Buy |
4,947
+95
| +2% | +$5.36K | 0.26% | 79 |
|
|
2018
Q1 | $252K | Buy |
4,852
+408
| +9% | +$22K | 0.23% | 86 |
|
|
2017
Q4 | $239K | Hold |
4,444
| – | – | 0.21% | 82 |
|
|
2017
Q3 | $271K | Hold |
4,444
| – | – | 0.26% | 75 |
|
|
2017
Q2 | $272K | Buy |
4,444
+325
| +8% | +$19.8K | 0.26% | 75 |
|
|
2017
Q1 | $250K | Hold |
4,119
| – | – | 0.23% | 83 |
|
|
2016
Q4 | $231K | Buy |
+4,119
| New | +$241K | 0.23% | 79 |
|
Other funds holding MRK
ECSS
Lederer & Associates Investment Counsel's MRK Position: Q2 2026 in Review
Lederer & Associates Investment Counsel increased its Merck (MRK) stake by 0.88% in Q2 2026, buying an estimated $9.83K and bringing the position to 9,603 shares worth $1.23M. The position accounts for 0.81% of the portfolio, ranked #43.
Lederer & Associates Investment Counsel first reported a position in MRK in Q4 2016 and has held it in 39 quarters since. 1,752 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Lederer & Associates Investment Counsel held 9,603 shares of Merck worth $1.23M as of Q2 2026.
- Lederer & Associates Investment Counsel bought 84 Merck shares in Q2 2026, an estimated $9.83K.
- Merck made up 0.81% of Lederer & Associates Investment Counsel's portfolio in Q2 2026, its #43 holding.
- Lederer & Associates Investment Counsel first reported a position in Merck in Q4 2016 and has held it in 39 quarters since.
- 1,752 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Lederer & Associates Investment Counsel's 13F filing for Q2 2026, filed 10 Jul 2026.